Comparing the Effectiveness of Triamcinolone Acetonide and Vitamin D3 Injections in Treating Spot baldness

A Comparative Study To Evaluate The Efficacy Of Intralesional Injections Of Triamcinolone Acetonide Versus Vitamin D3 In The Treatment Of Alopecia Areata - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070467

Enrollment

Registered

2024-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L63- Alopecia areata

Interventions

Intervention1: TRIAMCINOLONE ACETONIDE: Dose 10 mg/ml Route Intralesional Frequency Single dose only every 3 weeks Duration 12 weeks Control Intervention1: VITAMIN D3: Dose 1ml of 100000 IU Route Intr

Eligibility

Inclusion criteria

Inclusion criteria: Non-scarring, patchy hair loss over the scalp. Patients who have not received any treatment for Alopecia areata in past 4 weeks.

Exclusion criteria

Exclusion criteria: 1. Individuals under 18 years of age. 2. Women who are pregnant and lactating. 3. Patients with local site skin infection. 4. Patients on Immunosuppresants. 5. Patients with underlying malignancies. 6. Patients taking Vitamin D supplements in last 6 months.

Design outcomes

Primary

Measure	Time frame
Improvement of SALT Scoring and Digital Photography.Timepoint: 3rd week 6th week 9th week and 12th week	—

Secondary

Measure	Time frame
Adverse drug reactionTimepoint: 3, 6, 9 and 12th week	—

Countries

India

Contacts

Public ContactMedha Mishra

Eras Lucknow Medical College and Hospital

afrozabidi@gmail.com7275543349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026